National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 59276-59277 [2010-24140]

Download as PDF 59276 Federal Register / Vol. 75, No. 186 / Monday, September 27, 2010 / Notices Dated: September 20, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health [FR Doc. 2010–24139 Filed 9–24–10; 8:45 am] National Heart, Lung, and Blood Institute; Notice of Closed Meetings National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Clinical Center; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors of the NIH Clinical Center. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the CLINICAL CENTER, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors of the NIH Clinical Center. Date: October 4–5, 2010. Time: 8 a.m. to 2 p.m. Agenda: To review and evaluate the Department of Rehabilitation Medicine. Place: National Institutes of Health, Building 10, 10 Center Drive, Room 4–2551, Bethesda, MD 20892. Contact Person: David K Henderson, MD, Deputy Director for Clinical Care, Office of the Director, Clinical Center, National Institutes of Health, Building 10, Room 6– 1480, Bethesda, MD 20892, (301) 496–3515. This notice is being published less than 15 days prior to the meeting due to the urgent need tomeet timing limitations imposed by the intramural research review cycle. srobinson on DSKHWCL6B1PROD with NOTICES Dated: September 17, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–24145 Filed 9–24–10; 8:45 am] BILLING CODE 4140–01–P Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Translational Programs in Lung Diseases. Date: October 14–15, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Shelley S. Sehnert, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7206, Bethesda, MD 20892–7924, 301–435–0303, ssehnert@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Mentored Scientist Awards. Date: October 14–15, 2010. Time: 8:30 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Holly K. Krull, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7188, Bethesda, MD 20892–7924, 301–435–0280, krullh@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: September 21, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–24142 Filed 9–24–10; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 17:01 Sep 24, 2010 Jkt 220001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance (TB). Date: October 22, 2010. Time: 8 a.m. to 1 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6700B Rockledge Drive, 1216, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Lynn Rust, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/ NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 402–3938, lr228v@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance (CAP/HCAP). Date: November 8, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Melrose Hotel, 2430 Pennsylvania Ave., NW., Potomac III, Washington, DC 20037. Contact Person: Lynn Rust, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/ NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 402–3938, lr228v@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) E:\FR\FM\27SEN1.SGM 27SEN1 Federal Register / Vol. 75, No. 186 / Monday, September 27, 2010 / Notices Dated: September 21, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–24140 Filed 9–24–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention srobinson on DSKHWCL6B1PROD with NOTICES Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 75 FR 51091–93, dated August 18, 2010) is amended to reflect the reorganization of the Division of Adult and Community Health within the National Center for Chronic Disease Prevention and Health Promotion, Office of Noncommunicable Diseases, Injury and Environmental Health, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: Delete in its entirety the mission statement for the Division of Adult and Community Health (CUCE) and insert the following. Division of Adult and Community Health (CUCE). (1) Develops and promotes community-based interventions and programs; (2) provides national and international leadership in health education and health promotion; (3) conducts studies to enhance public health activities in health services and managed care; (4) manages public health research, training, cooperative, and intervention activities in diverse settings such as cities, universities, state health departments, and other countries; (5) promotes the understanding and improvement of the determinants and issues related to arthritis, aging, epilepsy, and emerging chronic disease and health promotion issues; (6) coordinates activities with other federal, state, and local governmental agencies, academia, and nongovernmental organizations, in cooperation with other components of NCCDPHP. Delete in its entirety the functional statement for the Office of the Director (CUCE1) and insert the following: VerDate Mar<15>2010 17:01 Sep 24, 2010 Jkt 220001 Office of the Director (CUCEI). (1) Manages, coordinates, and evaluates the activities and programs of the division; (2) ensures that division activities are coordinated with other components of CDC both within and outside the center, with federal, state, and local health agencies, and with voluntary and professional health agencies; (3) provides leadership and coordinates division responses to requests for research, consultation, training, collaboration, and technical assistance or information on managed care, health promotion, aging, epilepsy, and arthritis; (4) provides administrative, logistical, and management support for division field staff; (5) provides administrative and management support for the division including guidance on the organization of personnel and the use of financial resources, and oversight of grants, cooperative agreements, contracts, and reimbursable agreements; (6) provides leadership and technical assistance to communities to promote policy, systems, and environmental changes that improve community health; (7) supports a network of academic researchers, public health agencies, and community members that conducts applied research in disease prevention and control. Delete in their entirety the title and functional statement for the Arthritis, Epilepsy and Quality of Life Branch (CUCc) and insert the following: ¸ State Support, Arthritis, Epilepsy and Quality of Life Branch (CUCEC). (1) Directs and supports activities to reach people affected by arthritis and improve their quality of life by fostering public health science and translating science into population based interventions; (2) coordinates CDC Preventive Health and Health Services Block Grant (PHHSBG) activities and develops and administers guidelines, uniform reporting procedures, and evaluation criteria for state programs supported by PHHSBG; (3) directs and supports activities that improve quality of life for people affected by epilepsy, including improving access to appropriate medical care and self-management support, improving policy and systems to support people with epilepsy, supporting surveillance, epidemiologic, and prevention research, combating stigma and increasing public awareness and knowledge about epilepsy; (4) directs and administers surveillance efforts that provide knowledge to influence the public health community to improve health related quality of life and well-being through public health action; (5) develops, validates refines and promotes health-related quality of life and well-being measures for use in PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 59277 surveillance, program planning, evaluation and public health intervention and policy development; (6) directs and coordinates the evaluation of community and statebased intervention programs for arthritis and epilepsy; (7) develops arthritis and health-related quality of life epidemiology capacity and other programmatic capabilities in state health department settings; and (8) disseminates health promotion and disease prevention programs and information through state and national partners. Delete item (4) of the functional statement for the Emerging Investigations and Analytic Methods Branch (CUC1J and insert the following: (4) performs research on adverse childhood events, mental health, and alcohol. Delete in their entirety the title and functional statement for the Community Health and Program Services Branch (CUCEG) and insert the following: Community Health and Equity Branch (CUCEG). (1) Provides technical assistance to state and local health agencies, community-based organizations, academic institutions, and other federal, national, and international organizations to plan, implement, and evaluate communitybased chronic disease prevention and health promotion programs, with an emphasis on improving equity and reducing disparities; (2) develops, implements, and evaluates training in the areas of chronic disease intervention, social determinants of health, and community health promotion for state and local health departments, other agencies, and community organizations; (3) supports health promotion and disease prevention research conducted at university-based prevention centers; (4) develops chronic disease epidemiology capacity in state health departments through training and support of chronic disease field epidemiologists and other capacity building efforts; (5) provides professional statistical and programming services to the division, including assistance in design of data collection instruments, computer programming, and statistical analysis; (6) provides administrative and management support for the branch, including oversight of grants, cooperative agreements, contracts, and reimbursable agreements. E:\FR\FM\27SEN1.SGM 27SEN1

Agencies

[Federal Register Volume 75, Number 186 (Monday, September 27, 2010)]
[Notices]
[Pages 59276-59277]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-24140]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Targeted Clinical Trials To Reduce 
the Risk of Antimicrobial Resistance (TB).
    Date: October 22, 2010.
    Time: 8 a.m. to 1 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
1216, Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Lynn Rust, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 
402-3938, lr228v@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Targeted Clinical Trials To Reduce 
the Risk of Antimicrobial Resistance (CAP/HCAP).
    Date: November 8, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Melrose Hotel, 2430 Pennsylvania Ave., NW., Potomac III, 
Washington, DC 20037.
    Contact Person: Lynn Rust, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 
402-3938, lr228v@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


[[Page 59277]]


    Dated: September 21, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-24140 Filed 9-24-10; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.